<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38935565</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1545-861X</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>25</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>27</Day></PubDate></JournalIssue><Title>MMWR. Morbidity and mortality weekly report</Title><ISOAbbreviation>MMWR Morb Mortal Wkly Rep</ISOAbbreviation></Journal><ArticleTitle>Persistent Transmission of Circulating Vaccine-Derived Poliovirus - Somalia, January 2017-March 2024.</ArticleTitle><Pagination><StartPage>575</StartPage><EndPage>580</EndPage><MedlinePgn>575-580</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.15585/mmwr.mm7325a2</ELocationID><Abstract><AbstractText>Since the launch of the Global Polio Eradication Initiative in 1988, substantial progress has been made in the interruption of wild poliovirus (WPV) transmission worldwide: global eradication of WPV types 2 and 3 were certified in 2015 and 2019, respectively, and endemic transmission of WPV type 1 continues only in Afghanistan and Pakistan. After the synchronized global withdrawal of all serotype 2 oral poliovirus vaccines (OPVs) in 2016, widespread outbreaks of circulating vaccine-derived poliovirus type 2 (cVDPV2) have occurred, which are linked to areas with low population immunity to poliovirus. Officials in Somalia have detected ongoing cVDPV2 transmission since 2017. Polio vaccination coverage and surveillance data for Somalia were reviewed to assess this persistent transmission. During January 2017-March 2024, officials in Somalia detected 39 cVDPV2 cases in 14 of 20 regions, and transmission has spread to neighboring Ethiopia and Kenya. Since January 2021, 28 supplementary immunization activities (SIAs) targeting cVDPV2 were conducted in Somalia. Some parts of the country are security-compromised and inaccessible for vaccination campaigns. Among 1,921 children with nonpolio acute flaccid paralysis, 231 (12%) had not received OPV doses through routine immunization or SIAs, 95% of whom were from the South-Central region, and 60% of whom lived in inaccessible districts. Enhancing humanitarian negotiation measures in Somalia to enable vaccination of children in security-compromised areas and strengthening campaign quality in accessible areas will help interrupt cVDPV2 transmission.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mendes</LastName><ForeName>Amalia</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Mohamed</LastName><ForeName>Gedi Abdi</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Derow</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Stehling-Ariza</LastName><ForeName>Tasha</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Mohamed</LastName><ForeName>Abdinoor</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Mengistu</LastName><ForeName>Kumlachew</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Bullard</LastName><ForeName>Kelley</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Akbar</LastName><ForeName>Irfan Elahi</ForeName><Initials>IE</Initials></Author><Author ValidYN="Y"><LastName>Shukla</LastName><ForeName>Hemant</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Al Safadi</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Maureen</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>MMWR Morb Mortal Wkly Rep</MedlineTA><NlmUniqueID>7802429</NlmUniqueID><ISSNLinking>0149-2195</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012998" MajorTopicYN="N" Type="Geographic">Somalia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="Y">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073887" MajorTopicYN="N">Vaccination Coverage</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>27</Day><Hour>13</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38935565</ArticleId><ArticleId IdType="pmc">PMC11254344</ArticleId><ArticleId IdType="doi">10.15585/mmwr.mm7325a2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BBC News. Somalia: the world’s most failed state? London, England: BBC; 2011. https://www.bbc.com/news/world-africa-14094503</Citation></Reference><Reference><Citation>Mbaeyi C, Kamadjeu R, Mahamud A, Webeck J, Erhardt D, Mulugeta A. Progress toward polio eradication–Somalia, 1998–2013. J Infect Dis 2014;210 (Suppl 1):S173–80. 10.1093/infdis/jit808</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jit808</ArticleId><ArticleId IdType="pmc">PMC4703039</ArticleId><ArticleId IdType="pubmed">25316833</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishore N, Krow-Lucal E, Diop OM, et al. Surveillance to track progress toward polio eradication—worldwide, 2022–2023. MMWR Morb Mortal Wkly Rep 2024;73:278–85. 10.15585/mmwr.mm7313a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7313a1</ArticleId><ArticleId IdType="pmc">PMC10997045</ArticleId><ArticleId IdType="pubmed">38573841</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigouette JP, Henderson E, Traoré MA, et al. Update on vaccine-derived poliovirus outbreaks—worldwide, January 2021–December 2022. MMWR Morb Mortal Wkly Rep 2023;72:366–71. 10.15585/mmwr.mm7214a3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7214a3</ArticleId><ArticleId IdType="pmc">PMC10078846</ArticleId><ArticleId IdType="pubmed">37022974</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Polio Eradication Initiative. GPEI strategy 2022–2026. Geneva, Switzerland: World Health Organization; 2022. https://polioeradication.org/gpei-strategy-2022-2026/</Citation></Reference><Reference><Citation>World Health Organization. Standard operating procedures: responding to a poliovurus event or outbreak, version 4. Geneva, Switzerland: World Health Organization; 2022. https://www.who.int/publications/i/item/9789240049154</Citation></Reference><Reference><Citation>World Health Organization. Immunization Somalia 2023 country profile. Geneva, Switzerland: World Health Organization; 2023. https://www.who.int/publications/m/item/immunization-somalia-2023-country-profile</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>